6-Methylpurine-2'-deoxy-2'-fluoro-beta-D-arabinoriboside

6-Methylpurine-2'-deoxy-2'-fluoro-beta-D-arabinoriboside Suppliers list

Company Name:	Zhengzhou Granlen Sciences, ltd.
Tel:	0371-85513397 +86-18610099868
Email:	info@granlen.com

Company Name:	SHANGHAI T&W PHARMACEUTICAL CO., LTD.
Tel:	+86-021-61551413
Email:	contact@trustwe.com

6-Methylpurine-2'-deoxy-2'-fluoro-beta-D-arabinoriboside manufacturers

6-Methylpurine-2'-deoxy-2'-fluoro-beta-D-arabinoriboside Basic information

Product Name:	6-Methylpurine-2'-deoxy-2'-fluoro-beta-D-arabinoriboside
Synonyms:	6-Methylpurine-2'-deoxy-2'-fluoro-beta-D-arabinoriboside;6-Methylpurine-2’-fluoro-β-D-arabinoriboside;1-(2'-Deoxy-2'-fluoro-b-D-arabinofuranosyl)6-methylpurine;6-Methylpurine-2’-deoxy-2’-fluoro-β-D-arabinoriboside;6-Methylpurine-2’-deoxy-2’-fluoro-beta-D-arabinoriboside
CAS:	2095417-72-2
MF:	C11H13FN4O3
MW:	268.24
EINECS:
Product Categories:
Mol File:	2095417-72-2.mol

6-Methylpurine-2'-deoxy-2'-fluoro-beta-D-arabinoriboside Chemical Properties

Safety Information

MSDS Information

6-Methylpurine-2'-deoxy-2'-fluoro-beta-D-arabinoriboside Usage And Synthesis

Uses	6-Methylpurine-2’-deoxy-2’-fluoro-beta-D-arabinoriboside is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
References	[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005

6-Methylpurine-2'-deoxy-2'-fluoro-beta-D-arabinoriboside Preparation Products And Raw materials

Tag:6-Methylpurine-2'-deoxy-2'-fluoro-beta-D-arabinoriboside(2095417-72-2) Related Product Information

5-Chloro-2'-deoxyuridine Raltitrexed Capecitabine 6-Mercaptopurine Clofarabine Broxuridine